Your browser doesn't support javascript.
loading
ATR expands embryonic stem cell fate potential in response to replication stress.
Atashpaz, Sina; Samadi Shams, Sara; Gonzalez, Javier Martin; Sebestyén, Endre; Arghavanifard, Negar; Gnocchi, Andrea; Albers, Eliene; Minardi, Simone; Faga, Giovanni; Soffientini, Paolo; Allievi, Elisa; Cancila, Valeria; Bachi, Angela; Fernández-Capetillo, Óscar; Tripodo, Claudio; Ferrari, Francesco; López-Contreras, Andrés Joaquin; Costanzo, Vincenzo.
Affiliation
  • Atashpaz S; IFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Samadi Shams S; IFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Gonzalez JM; Transgenic Core Facility, University of Copenhagen, Copenhagen, Denmark.
  • Sebestyén E; IFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Arghavanifard N; IFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Gnocchi A; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
  • Albers E; IFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Minardi S; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
  • Faga G; Center for Chromosome Stability and Center for Healthy Aging, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Soffientini P; IFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Allievi E; Cogentech, IFOM-The FIRC Institute of Molecular Oncology Milan, Milan, Italy.
  • Cancila V; Experimental Therapeutics Program, IFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Bachi A; IFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Fernández-Capetillo Ó; Cogentech, IFOM-The FIRC Institute of Molecular Oncology Milan, Milan, Italy.
  • Tripodo C; Tumor Immunology Unit, Department of Health Sciences, Human Pathology Section, University of Palermo School of Medicine Palermo, Palermo, Italy.
  • Ferrari F; IFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.
  • López-Contreras AJ; Spanish National Cancer Research Center, Madrid, Spain.
  • Costanzo V; Science for Life Laboratory, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
Elife ; 92020 03 12.
Article in En | MEDLINE | ID: mdl-32163370
ABSTRACT
Unrepaired DNA damage during embryonic development can be potentially inherited by a large population of cells. However, the quality control mechanisms that minimize the contribution of damaged cells to developing embryos remain poorly understood. Here, we uncovered an ATR- and CHK1-mediated transcriptional response to replication stress (RS) in mouse embryonic stem cells (ESCs) that induces genes expressed in totipotent two-cell (2C) stage embryos and 2C-like cells. This response is mediated by Dux, a multicopy retrogene defining the cleavage-specific transcriptional program in placental mammals. In response to RS, DUX triggers the transcription of 2C-like markers such as murine endogenous retrovirus-like elements (MERVL) and Zscan4. This response can also be elicited by ETAA1-mediated ATR activation in the absence of RS. ATR-mediated activation of DUX requires GRSF1-dependent post-transcriptional regulation of Dux mRNA. Strikingly, activation of ATR expands ESCs fate potential by extending their contribution to both embryonic and extra-embryonic tissues. These findings define a novel ATR dependent pathway involved in maintaining genome stability in developing embryos by controlling ESCs fate in response to RS.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Checkpoint Kinase 1 Limits: Animals Language: En Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Checkpoint Kinase 1 Limits: Animals Language: En Year: 2020 Type: Article